Stock Code: Yifan Pharmaceutical Co.Ltd(002019) stock abbreviation: Yifan Pharmaceutical Co.Ltd(002019) Announcement No.: 2022040 Yifan Pharmaceutical Co.Ltd(002019)
Notice on holding 2021 annual online performance briefing
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Yifan Pharmaceutical Co.Ltd(002019) 2022 is scheduled to hold the 2021 annual performance presentation at panorama.com from 15:00 to 17:00 on April 20, 2022. This annual performance presentation will be held remotely. Investors can log in to the “investor relations interactive platform” of panorama.com（ https://ir.p5w.net. ）Participate in this annual performance presentation or directly enter the roadshow Hall of Yifan Pharmaceutical Co., Ltd（ https://ir.p5w.net./c/ Yifan Pharmaceutical Co.Ltd(002019) .shtml ）Participate in this annual performance briefing.
Present at this briefing are: Mr. Cheng Xianfeng, chairman and general manager of the company, Mr. Lin Xing, director and deputy general manager, Ms. Yu Haixia, chief financial officer, Mr. Liu Hongquan, independent director, Mr. Feng Deqi, Secretary of the board of directors, etc.
In order to fully respect investors and improve the pertinence of exchanges, we are now soliciting questions from investors in advance for the company’s 2021 annual performance description, and widely listen to the opinions and suggestions of investors. Investors can visit before 17:00 on Tuesday, April 19, 2022 https://ir.p5w.net./zj/ , or scan the QR code below to enter the question collection topic page. The company will answer the questions generally concerned by investors at the 2021 annual performance briefing.
Investors are welcome to actively participate in this online briefing.
(QR code of question collection special page)
It is hereby announced.
Yifan Pharmaceutical Co.Ltd(002019) board of directors April 13, 2022
